LGL PARTNERS, LLC: EQT position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of LGL PARTNERS, LLC on EQT, newest first. How the timeline and the estimate are built.
LGL PARTNERS, LLC held 0 EQT shares at 2025-12-31 per its 13F-HR filed 2026-02-09.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -10,076 shares
13F-HR 0001653202-26-000001 filed by LGL PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 10,076 sharesChange vs previous 13F +30 shares
0.23% of the 13F portfolio, value $548,442.
13F-HR 0001653202-25-000005 filed by LGL PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 10,046 sharesChange vs previous 13F +29 shares
0.23% of the 13F portfolio, value $514,742.
13F-HR 0001653202-25-000003 filed by LGL PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 10,017 sharesChange vs previous 13F +33 shares
0.26% of the 13F portfolio, value $535,210.
13F-HR 0001653202-25-000002 filed by LGL PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 9,984 sharesChange vs previous 13F +35 shares
0.07% of the 13F portfolio, value $460,351.
13F-HR 0000919574-25-000807 filed by LGL PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 9,949 sharesChange vs previous 13F not available
0.05% of the 13F portfolio, value $364,547.
13F-HR 0000919574-24-006273 filed by LGL PARTNERS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).